Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells
/in International Publications, Malignant Lymphoma /von 2005-10-07 / Hum. Immunol. 2005 Sep;66(9):938-49Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma
/in International Publications, Malignant Lymphoma /von 2005-10-01 / Curr Gene Ther 2005 Oct;5(5):511-21B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells
/in International Publications, Malignant Lymphoma /von 2005-09-26 / Clin. Immunol. 2006 Jan;118(1):66-76B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice
/in International Publications, Malignant Lymphoma /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):461-6Immunotherapy in multiple myeloma–possibility or probability?
/in International Publications, Malignant Lymphoma /von 2005-08-01 / Br. J. Haematol. 2005 Aug;130(3):344-62Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
/in International Publications, Malignant Lymphoma /von 2005-07-15 / Cancer Immunol. Immunother. 2006 Apr;55(4):420-32Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy
/in International Publications, Malignant Lymphoma /von 2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):322-31Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
/in International Publications, Malignant Lymphoma /von 2005-07-01 / Cancer Res. 2005 Jul;65(13):5958-64Vaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies
/in International Publications, Malignant Lymphoma /von 2005-06-01 / Curr Opin Investig Drugs 2005 Jun;6(6):597-604
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de